Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy.

Imagen de María del Pilar Torres-González
PDF versionPDF version
TítuloHoly Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy.
Publication TypeJournal Article
Year of Publication2013
AutoresShimizu, T, Torres, MP, Chakraborty, S, Souchek, JJ, Rachagani, S, Kaur, S, Macha, M, Ganti, AK, Hauke, RJ, Batra, SK
JournalCancer Lett
Volume336
Issue2
Pagination270-80
Date Published2013 Aug 19
ISSN1872-7980
Abstract

There is an urgent need to develop alternative therapies against lethal pancreatic cancer (PC). Ocimum sanctum ("Holy Basil") has been used for thousands of years in traditional Indian medicine, but its anti-tumorigenic effect remains largely unexplored. Here, we show that extracts of O. sanctum leaves inhibit the proliferation, migration, invasion, and induce apoptosis of PC cells in vitro. The expression of genes that promote the proliferation, migration and invasion of PC cells including activated ERK-1/2, FAK, and p65 (subunit of NF-κB), was downregulated in PC cells after O. sanctum treatment. Intraperitoneal injections of the aqueous extract significantly inhibited the growth of orthotopically transplanted PC cells in vivo (p<0.05). Genes that inhibit metastasis (E-cadherin) and induce apoptosis (BAD) were significantly upregulated in tumors isolated from mice treated with O. sanctum extracts, while genes that promote survival (Bcl-2 and Bcl-xL) and chemo/radiation resistance (AURKA, Chk1 and Survivin) were downregulated. Overall, our study suggests that leaves of O. sanctum could be a potential source of novel anticancer compounds in the future.

DOI10.1016/j.canlet.2013.03.017
Alternate JournalCancer Lett.
PubMed ID23523869
PubMed Central IDPMC3700662
Grant ListP50 CA127297 / CA / NCI NIH HHS / United States
P50 CA127297 / CA / NCI NIH HHS / United States
T32CA009476 / CA / NCI NIH HHS / United States
U01 CA111294 / CA / NCI NIH HHS / United States
U54 CA160163 / CA / NCI NIH HHS / United States